Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Nurix Therapeutics Inc (NRIX)

188 + Investors. Track Smart Money conviction in NRIX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +9
Streak
3Q ▲
Buyers last Q
58%

Smart Money Signals — NRIX

Based on 189 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added NRIX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
189 hedge funds hold NRIX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +13% more funds vs a year ago

fund count last 6Q
+22 new funds entered over the past year (+13% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 58% buying

104 buying76 selling
Last quarter: 104 funds bought or added vs 76 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~40 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 26 → 33 → 41 → 40. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

50% of holders stayed for 2+ years

■ 50% conviction (2yr+) ■ 25% medium ■ 25% new
94 out of 189 hedge funds have held NRIX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +3%, value -16%

Value
-16%
Shares
+3%
Last quarter: funds added +3% more shares while total portfolio value only changed -16%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

28 → 26 → 33 → 41 → 40 new funds/Q
New funds entering each quarter: 26 → 33 → 41 → 40. A growing number of institutions are discovering NRIX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 56% veterans vs 25% newcomers

■ 56% veterans ■ 19% 1-2yr ■ 25% new
Entry-cohort mix of 192 holders: 108 (56%) are 2+ year veterans, 36 entered 1–2 years ago, and 48 (25%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 30% AUM from major funds

30% from top-100 AUM funds
45 of 189 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NRIX

In 2026 Q1, 104 hedge funds were net buyers of NRIX (40 opened a new position, 64 added to an existing one), while 76 reduced or exited (45 trimmed, 31 sold completely) — a 58% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 30% of total institutional value in NRIX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +9 funds (more new holders than closures). Total institutional holders: 189.

Hedge Fund Ownership: NRIX

How many hedge funds hold NRIX — quarterly history vs. share price
Quarterly hedge fund ownership of NRIX vs. share price

Market Analysis: NRIX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NRIX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Nurix Therapeutics Inc (NRIX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NRIX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 85d ago
NRIX
+21.7%
XLV
+2.8%

NRIX outperformed XLV by +18.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 40d ago
NRIX
+19.0%
XLV
+3.9%

Since the filing became public, NRIX outperformed XLV by +15.1% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

25 top-rated funds 4 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
3.2
/ 10
conviction
Hedge Fund Positioning: NRIX
188 + Investors

Track Smart Money conviction in NRIX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 188 180 4.44%
13F Shares 117M 114M 3.06%
Total Value $1.75B $2.10B -16.43%
New Positions 39 41 -2
Increased Positions 64 92 -28
Closed Positions 31 31 -
Reduced Positions 43 28 +15
Total Calls 2 3 -33.33%
Total Puts 1 2 -50.0%
PUT/CALL Ratio 0.5 0.67 Bullish

Statistics: NRIX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

188 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NRIX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 NRIX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Redmile Group, LLC 7.94% 7,732,808 $119.9M
2 Trails Edge Capital Partners, LP 6.19% 1,743,220 $27.0M
3 General Atlantic, L.P. 2.96% 4,101,865 $63.6M
4 Vestal Point Capital, LP 2.82% 6,500,000 $100.8M
5 Commodore Capital LP 2.04% 2,275,000 $35.3M
6 Elmind Capital, LP 2.02% 460,000 $7.1M
7 Deep Track Capital, LP 1.61% 6,345,244 $98.4M
8 Foresite Capital Management V, LLC 1.52% 265,000 $4.1M
9 Verdad Advisers, LP 1.46% 83,425 $1.3M
10 Kynam Capital Management, LP 1.14% 1,194,757 $18.5M
11 Perceptive Advisors LLC 1.13% 3,710,877 $57.5M
12 Flax Pond Capital, LLC 1.00% 80,200 $1.2M
13 HighVista Strategies LLC 0.97% 226,546 $3.5M
14 Stempoint Capital LP 0.95% 315,226 $4.9M
15 Braidwell LP 0.91% 1,750,766 $27.1M
16 Longaeva Partners L.P. 0.86% 1,490,202 $23.1M
17 Affinity Asset Advisors, LLC 0.77% 967,620 $15.0M
18 WestHill Financial Advisors, Inc. 0.68% 228,333 $3.5M
19 Rhenman & Partners Asset Management AB 0.60% 313,500 $4.9M
20 Soleus Capital Management, L.P. 0.59% 938,163 $14.5M
21 Integral Health Asset Management, LLC 0.52% 700,000 $10.8M
22 Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group 0.50% 85,000 $1.3M
23 Baker BROS. Advisors LP 0.41% 4,658,556 $72.2M
24 Rubric Capital Management LP 0.41% 2,473,885 $38.3M
25 AlphaCentric Advisors LLC 0.40% 25,571 $396K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Nurix Therapeutics Inc (NRIX)

What does the Smart Money Trend signal show for NRIX?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added NRIX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NRIX?

Slight buying edge — 58% buying: Last quarter: 104 funds bought or added vs 76 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for NRIX holders?

Strong quality — 30% AUM from major funds: 45 of 189 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held NRIX?

50% of holders stayed for 2+ years: 94 out of 189 hedge funds have held NRIX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Nurix Therapeutics Inc (NRIX) following the 2026 Q1 hedge fund 13F filings?

As of today, NRIX has moved +19.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +15.1%. Since the quarter end (March 31, 2026), NRIX has gained +21.7% vs +2.8% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →